Dengue Virus Cases Surge Amidst COVID-19 in Pakistan | IDR – Dove Medical Press

Introduction

Dengue is a mosquito-borne viral infection typically seen in tropical and subtropical regions. It has four different strains (DENV-1, DENV-2, DENV-3, and DENV-4), all belonging to the Flaviviridae family.1 The infection transmits through bites of the infected female Aedes aegypti or Aedes albopictus mosquito that has previously been infected by biting a person with the dengue virus.1 In 1994, Pakistan reported the first confirmed outbreak of dengue fever. However, the annual epidemic trend and unexpected rise in cases first became apparent in November 2005.2,3 Since 2010, Pakistan has reported tremendous numbers of dengue cases, with 2020 alone amounting to 47,120 confirmed cases including 75 deaths4. As of 25 November 2021, a total of 48,906 cases of Dengue including 183 deaths have been reported.5 Unfortunately, this debilitating, mosquito-borne disease is now endemic in Pakistan circulating throughout the year with the highest prevalence in the post-monsoon season with all four provinces being majorly affected.3 The rapid spread of the infection is attributed to irregular monsoon rains and rising temperatures linked to climate change. Such favorable factors allow for ideal mosquito breeding conditions thus aids virus survival.6 Adverse circumstances including inadequate sanitation and garbage disposal, unsafe drinking water, overcrowded cities, and breakneck urbanization, lack of vector control strategy, and the clinical management of hospitalized dengue cases have promoted the transmission of the infectious agent.1 On October 2nd, 2021, Pakistan documented 1664 COVID-19 cases and 46 deaths over the span of 24 hours.7 The number of active COVID-19 cases has plummeted to 46,934 with a high recovery rate, the lowest it has been in the past two months.7 Pakistan has administered a total of 82,830,350 COVID-19 vaccines, vaccinating about 19.1% of the country’s population as of October 2021.7 Since 2020, studies have reported numerous cases of a new coinfection of COVID-19 and dengue that has a higher mortality rate than patients only diagnosed with COVID-19.5 The two viruses have been shown to have overlapping clinical and laboratory features. Both are commonly characterized by fever, severe headache (clinical presentation), thrombocytopenia and leukocytopenia (on lab findings). The coinfected group has also observed high percentages of bilirubin, alanine amino transferase, creatinine, prothrombin time, urea, and creatinine phosphokinase.5 From June 23rd through 15th July 2021, 20 suspected patients of COVID-19 with respiratory distress, were admitted to Holy Family Hospital in Rawalpindi. Upon collection of respiratory swabs, it was found that all 20 patients tested positive for SARS-CoV-2 and dengue virus serotype-2 (DENV-2).8 The province of Punjab has reported a total of 1082 cases of dengue fever this year with Lahore at high risk of facing a major dengue outbreak following the recent rainfalls.9,10 This has led to serious public health crises due to the absence of active surveillance and diversion of entire efforts towards the fight against COVID-19, lack of lockdown regulations, meager implementation of preventive measures, paucity of knowledge in the public, and mass gatherings in worship places.11,12

Challenges and Efforts

Just as nations like Saudi Arabia, Brazil, Yemen, Sudan, and Madagascar are presently confronting episodes of dengue with COVID-19, so is Pakistan.13,14 Significant similarities in the haematological and biochemical markers like fever, headache, and body pain, and laboratory characteristics like thrombocytopenia and leukopenia between the dengue and COVID-19 infected patients are of concern, especially for Pakistan’s ill-equipped healthcare infrastructure.4 The co-epidemic of COVID-19 and dengue in Pakistan has brought about numerous public health challenges on the delicate healthcare framework of the nation. Moreover, since dengue infection (DENV) transmission is strongly driven by human mobility, changes associated with the pandemic have been hypothesized to impact dengue incidence. By debilitating human contact, COVID-19 control measures have also disturbed dengue vector control medications, which are the most effective way of mitigating the disease.15

Pakistan’s provincial healthcare framework has been terribly neglected due to political interference, with a weak administrative system. Most imperatively, all vertical programs are run by the Federal government without the coordination of the Common Government.4,16 This disregard has resulted in enormous disparities between getting access to basic healthcare facilities for both the poor and wealthy.17 There is also much less information accessible in Pakistan on the prevalence and clinical and laboratory characteristics of dengue, and hence complications in epidemiological surveillance.2 This coupled with a colossal burden on finances within the country complicates vector control measures. Moreover, limitations in essential resources for healthcare professionals (HCPs) battling COVID-19 and other endemic illnesses like dengue and chikungunya, as well as COVID-19-Associated Mucormycosis (CAM) in severely ill COVID-19 patients will inevitably add to both mortality and morbidity.18,19 Lastly, maintaining social distancing in urban centres like Karachi and Lahore is difficult, and stigma around COVID-19 vaccinations further creates vulnerabilities that may impose serious strain on healthcare infrastructure.20 Furthermore, a reliance on unsustainable sources of income and high levels of poverty are adding to higher mobility, reducing implementation of quarantine, and hence contributing to both Dengue and COVID-19.4,21 The implications of such constrained resources with poor distancing measures exacerbates and prolongs both the development and implementation of healthcare measures. However, despite socioeconomic disparities, economic failure and difficulties with public health measures, Pakistan continues to be persistent in its plans to address Dengue and COVID-19.

In response to the dengue outbreak and to assist with vector control, WHO entomologists studied the Aedes mosquito in Karachi during the 2005 outbreak and used this information to design Pakistan-specific control interventions.2 In the past outbreaks, chemical and environmental management techniques have been used to curb the spread of dengue including fumigation and spraying, improving solid waste disposal, and applying insecticides to larval habitats. Alternatively, using the media to promote healthy practices such as drinking large amounts of fluids, rest, complete blood count (CBC) if fever persists beyond 3 days, intake of Oral rehydration salt (ORS), and keeping body temperature below 39 C. Community-based programs, provision of long-term insecticides, insecticide treated nets (ITNs) to vulnerable groups such as children and pregnant woman, and involvement of provincial and municipal health authorities in surveillance and policies have proven helpful.3 Currently, the WHO country office (WCO) is supporting the government of Pakistan in the following ways:22 Developing a comprehensive dengue response plan covering case management, dengue surveillance, vector control, and community mobilization and coordination along with donation of mosquito fogging equipment with thousands of dengue awareness flyers, posters, banners and brochures, which were distributed in schools, railway stations and other public places to provide information on the dengue virus.22 Response measures taken by the Ministry of Health in Pakistan include the formation of The National Institute of Health Emergency Operation Center (NIH EOC) since 16 September 2019 to monitor the disease situation in constant liaison with the provincial health departments.22 In addition, rapid response teams are in place to conduct active response at household level and in infected areas and all provinces have arranged free of charge diagnostic and clinical management services for the cases.22 At the moment, there is no suitable treatment available for the dengue fever caused by this virus or an effective vaccine, and clinicians can only halt the progression of the viral infection to its hemorrhagic state.23

Recommendations and Conclusion

Exceptional measures should be taken like large investments and research in epidemiological, diagnostics, and vaccine advancement research, therapeutic and protective supplies are required to tackle the epidemic productively. Careful surveillance, viral identification tests, and disinfecting large areas should be prioritized to identify and restrain the transmission of viruses.11 Moreover, employing a multisectoral approach involving provincial and municipal healthcare authorities to enforce strict public health measures such as checking body temperature in public spaces, encouraging no touch delivery services, and social distancing is recommended. Preventive measures that individuals should adopt include using insect repellent, keeping bodies covered by wearing long sleeved shirts and pants, drinking clean water, using insecticide sprays in dark corners of your home, covering all the water storage containers, and storing them.

Complete blood count (CBC) is the single most common test performed in patients. In dengue, the CBC is characterized by progressive leukopenia followed by a rapid decrease in the platelet count, while in contrast, patients with COVID-19 may present with leukopenia or leukocytosis, eosinopenia, and lymphopenia which is the most common abnormality, hence makes it a useful and reliable indicator of the severity of the disease. To add, it is also cost-effective and thus feasible to implement in Pakistan. Other than that, double laboratory testing will be a more accurate source of diagnosis differentiating the two. DEN-PCR is successful for diagnosis in Pakistan for both primary and secondary dengue infections.24 Although serum antibody test may be used for differential diagnosis, HCPs must be careful to avoid false positive cases.25 Donation of mosquito fogging equipment, along with dengue awareness flyers, posters, banners, and brochures, which can be distributed in public places to provide information on the Dengue virus is also recommended. Lastly, the continual use of smart lockdown in vulnerable areas of the city to address COVID-19 can help reduce economic strain on those with unsustainable incomes, whereas travel restrictions within the city for unvaccinated individuals increase the rate of vaccination. More importantly, efforts such as counseling services and a mental health hotline are to be considered for HCPs who face high levels of burnout.26-28

In conclusion, Pakistan is currently facing multiple outbreaks of Dengue and COVID-19 that have exacerbated challenges for a weak healthcare system. Coupled with socioeconomic disparities, financial challenges, a slow vaccination rate, multiple clinical similarities, weak social distancing and increasing workload for HCPs, it is becoming difficult to mitigate these outbreaks. However, continual efforts by the WHO as well as preventative measures and epidemiological surveillance will aid this process.